Withdrawal: Nuclear factor-κB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis.

Wu, Shufang; Flint, Janna K.; Rezvani, Geoffrey; Luca, Francesco De

doi:10.1074/jbc.w120.015606

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One of the limitations of our study was that we did not investigate osteochondroprogenitor differentiation into chondrocytes or the process of chondrocyte-driven endochondral ossification (39)(40)(41). Chondrogenic differentiation, proliferation, and hypertrophy is controlled by NF-κB subunit p65 activity (42,43). Nevertheless, recent work supports our model and provides evidence for the role of BCL3 in chondrocytic callus-driven fracture healing, in which Bcl3 −/− mice exhibit delayed chondrocyte hypertrophy that is rescued with BCL3 overexpression (44).…”

Section: Discussionmentioning

confidence: 60%

IĸB Protein BCL3 as a Controller of Osteogenesis and Bone Health

Jaffery

Huesa

Chilaka

et al. 2023

Arthritis & Rheumatology

View full text Add to dashboard Cite

ObjectiveIĸB protein B‐cell lymphoma 3‐encoded protein (BCL3) is a regulator of the NF‐κB family of transcription factors. NF‐κB signalling fundamentally influences the fate of bone‐forming osteoblasts and bone‐resorbing osteoclasts, but the role of BCL3 in bone biology has not been investigated. The objective of this study was to evaluate BCL3 in skeletal development, maintenance and osteoarthritic pathology.MethodsTo assess the contribution of BCL3 to skeletal homeostasis, neonatal mice (n = 6‐14) lacking BCL3 (Bcl3−/−) and WT controls were characterised for bone phenotype and density. To reveal the contribution to bone phenotype by the osteoblast compartment in Bcl3−/− mice, transcriptomic analysis of early osteogenic differentiation and cellular function (n = 3‐7) were assessed. Osteoclast differentiation and function in Bcl3−/− mice (n = 3‐5) was assessed. Adult 20‐week Bcl3−/− and WT mice bone phenotype, strength and turnover were assessed. A destabilisation of the medial meniscus (DMM) model of osteoarthritic ostephytogenesis was utilised to understand adult bone formation in Bcl3−/− mice (n = 11‐13).ResultsEvaluation of Bcl3−/− mice revealed congenitally increased bone density, long bone dwarfism, increased bone biomechanical strength and altered bone turnover. Molecular and cellular characterisation of mesenchymal precursors showed that Bcl3−/− cells display an accelerated osteogenic transcriptional profile that leads to enhanced differentiation into osteoblasts with increased functional activity; which could be reversed with a mimetic peptide. In a model of osteoarthritis‐induced osteophytogenesis, Bcl3−/− mice exhibit decreased pathological osteophyte formation (P < 0.05).ConclusionCumulatively, these findings demonstrate that BCL3 controls developmental mineralisation to enable appropriate bone formation, whilst in a pathological setting it contributes to skeletal pathology.image

show abstract